Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab, Pulmagen Therapeutics Sinergy LtdfiledCriticalAstrazeneca Ab
Priority to ECSP12011641priorityCriticalpatent/ECSP12011641A/en
Publication of ECSP12011641ApublicationCriticalpatent/ECSP12011641A/en
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Abstract
Derivados de amida espirocíclica de fórmula I, donde ArCH2CH2NH- representa un grupo de unión ?-adrenoceptor, procesos para su preparación, composiciones farmacéuticas que los contienen, un proceso para preparar dichas composiciones farmacéuticas, su uso en terapia, e intermediarios para uso en su preparación.Spirocyclic amide derivatives of formula I, where ArCH2CH2NH- represents a? -Adrenoceptor binding group, processes for their preparation, pharmaceutical compositions containing them, a process for preparing said pharmaceutical compositions, their use in therapy, and intermediates for use in their preparation.
ECSP120116412012-01-312012-01-31
DERIVATIVES OF SPIROCYCLIC AMIDAS
ECSP12011641A
(en)
uses of a compound of formula (b), compounds, pharmaceutical composition, method of preparing the compound and use of an effective amount of a compound